UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Immunotherapy in non-small cell lung cancer: advancements and challenges

Chinese medical journal, 2021-05, Vol.134 (10), p.1135-1137

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeted therapies for patients with advanced NSCLC harboring wild‐type EGFR: what's new and what's enough

Ai zheng, 2015-07, Vol.34 (3), p.1-10, Article 31

2015

Link zum Volltext

Verfügbarkeit prüfen

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study

Frontiers in oncology, 2021-11, Vol.11, p.745699-745699

2021

Link zum Volltext

Verfügbarkeit prüfen

Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung Adenocarcinoma

Disease markers, 2021, Vol.2021, p.3776854-8

2021

Link zum Volltext

Verfügbarkeit prüfen

Blood-based Tumor Markers in Lung Cancer

Zhongguo fei ai za zhi, 2015-12, Vol.18 (12), p.770-780

Zhou, Caicun

2015

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis

PloS one, 2014-07, Vol.9 (7), p.e103431-e103431

2014

Link zum Volltext

Verfügbarkeit prüfen

Comparison among different presentations of venous thromboembolism because of lung cancer

The clinical respiratory journal, 2019-09, Vol.13 (9), p.574-582

2019

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of chemotherapy in patients with EGFR mutation-negative non-small cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2013-05, Vol.35 (5), p.386

2013

Link zum Volltext

Verfügbarkeit prüfen

Transition from Ambrisentan to Bosentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study

Canadian respiratory journal, 2018-01, Vol.2018, p.9836820-5

2018

Link zum Volltext

Verfügbarkeit prüfen

Endobronchial ultrasound‐guided transbronchial needle aspiration for diagnosing mediastinal lymphadenectasis: a cohort study from a single center

The clinical respiratory journal, 2017-03, Vol.11 (2), p.159-167

2017

Link zum Volltext

Verfügbarkeit prüfen

Inverse Relation of Total Serum Bilirubin to Coronary Artery Calcification Score Detected by Multidetector Computed Tomography in Males

Clinical cardiology (Mahwah, N.J.), 2012-05, Vol.35 (5), p.301-306

2012

Link zum Volltext

Verfügbarkeit prüfen

Significance of molecular technology in diagnosis and therapy of non-small-cell lung cancer

Zhonghua bing li xue za zhi, 2012-08, Vol.41 (8), p.570

2012

Link zum Volltext

Verfügbarkeit prüfen

Treatment of patients with ALK gene rearranged non-small cell lung cancer  after resistance to crizotinib

Zhongguo fei ai za zhi, 2015-02, Vol.18 (2), p.69-74

2015

Link zum Volltext

Verfügbarkeit prüfen

Maintenance therapy in advanced non-small cell lung cancer: controversy and consensus

Zhonghua jiehe he huxi zazhi, 2012-02, Vol.35 (2), p.91

2012

Link zum Volltext

Verfügbarkeit prüfen

SPOP promotes FADD degradation and inhibits NF-κB activity in non-small cell lung cancer

Biochemical and biophysical research communications, 2018-09, Vol.504 (1), p.289-294

2018

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines

Asian Pacific journal of cancer prevention : APJCP, 2012-01, Vol.13 (1), p.255-260

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer

Future oncology (London, England), 2021-03, Vol.17 (7), p.763-773

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum cytokine levels in patients with advanced non-small cell lung cancer： correlation with clinical outcome of erlotinib treatment

Chinese medical journal, 2013-10, Vol.126 (20), p.3931-3935

2013

Link zum Volltext

Verfügbarkeit prüfen

Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study

Journal of cancer research and clinical oncology, 2023-09, Vol.149 (12), p.10771-10780

2023

Link zum Volltext

Verfügbarkeit prüfen

Individualized Chemotherapy in Advanced NSCLC Patients Based on mRNA Levels of BRCA1 and RRM1

Chinese journal of cancer research, 2012-09, Vol.24 (3), p.226-231

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial-mesenchymal transition in non-small cell lung cancer

Respirology (Carlton, Vic.), 2009-04, Vol.14 (3), p.371-376

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of Erlotinib in the treatment for advanced non-small cell lung cancer in Chinese patients

Zhōnghuá zhŏngliú zázhì, 2010-02, Vol.32 (2), p.148

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of Wnt signaling suppression on gefitinib in non small cell lung cancer cell lines

Zhonghua bing li xue za zhi, 2013-07, Vol.42 (7), p.455

2013

Link zum Volltext

Verfügbarkeit prüfen

Survival without common toxicity criteria grade 3/4 toxicity following second-line treatment with pemetrexed for nonsquamous non-small cell lung cancer in Chinese patients

Chinese medical journal, 2013, Vol.126 (24), p.4624-4628

2013

Link zum Volltext

Verfügbarkeit prüfen

Correlation analysis between cytokines levels in serum and bronchoalveolar lavage fluid, blood T cell subsets and pneumoconiosis severity

Zhonghua laodong weisheng zhiyebing zazhi, 2012-04, Vol.30 (4), p.255

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(50)
Science & Technology
(42)
Life Sciences & Biomedicine
(39)
Male
(33)
Female
(28)
Middle Aged
(27)
Aged
(22)
Lung Neoplasms - Drug Therapy
(21)
Adult
(19)
Oncology
(19)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(18)
Lung Cancer
(18)
Lung Neoplasms - Pathology
(18)
Carcinoma, Non-Small-Cell Lung - Pathology
(12)
Mutation
(11)
Lung Neoplasms - Genetics
(10)
Respiratory System
(10)
Aged, 80 And Over
(9)
Carcinoma, Non-Small-Cell Lung - Genetics
(9)
Chemotherapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Immunotherapy in non-small cell lung cancer: advancements and challenges

Targeted therapies for patients with advanced NSCLC harboring wild‐type EGFR: what's new and what's enough

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study

Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung Adenocarcinoma

Blood-based Tumor Markers in Lung Cancer

Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis

Comparison among different presentations of venous thromboembolism because of lung cancer

Outcomes of chemotherapy in patients with EGFR mutation-negative non-small cell lung cancer

Transition from Ambrisentan to Bosentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study

Endobronchial ultrasound‐guided transbronchial needle aspiration for diagnosing mediastinal lymphadenectasis: a cohort study from a single center

Inverse Relation of Total Serum Bilirubin to Coronary Artery Calcification Score Detected by Multidetector Computed Tomography in Males

Significance of molecular technology in diagnosis and therapy of non-small-cell lung cancer

Treatment of patients with ALK gene rearranged non-small cell lung cancer  after resistance to crizotinib

Maintenance therapy in advanced non-small cell lung cancer: controversy and consensus

SPOP promotes FADD degradation and inhibits NF-κB activity in non-small cell lung cancer

MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines

Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer

Serum cytokine levels in patients with advanced non-small cell lung cancer： correlation with clinical outcome of erlotinib treatment

Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study

Individualized Chemotherapy in Advanced NSCLC Patients Based on mRNA Levels of BRCA1 and RRM1

Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial-mesenchymal transition in non-small cell lung cancer

Efficacy and safety of Erlotinib in the treatment for advanced non-small cell lung cancer in Chinese patients

Effect of Wnt signaling suppression on gefitinib in non small cell lung cancer cell lines

Survival without common toxicity criteria grade 3/4 toxicity following second-line treatment with pemetrexed for nonsquamous non-small cell lung cancer in Chinese patients

Correlation analysis between cytokines levels in serum and bronchoalveolar lavage fluid, blood T cell subsets and pneumoconiosis severity

Suchergebnisse filtern